MeUp to this point we have considered only increase of urine volume as a means of stone prevention. The effect of increased urine volume is to reduce urine supersaturation with respect to stone forming salts and therefore reduce the risk of crystal formation which is the basis for kidney stones.



Supersaturation with respect to the calcium stones depends upon urine concentrations of calcium, oxalate, phosphate, and citrate, and, in the case of calcium phosphate stones, or uric acid stones, urine pH. Giving citrate salts can reduce urine calcium excretion and increase urine citrate. Urine citrate binds urine calcium in a soluble citrate complex, which reduced calcium salt supersaturations. Citrate inhibits crystal formation, growth and aggregation. The alkaline citrate salts can raise urine pH.

relative risk vs urine citrate from Curhan control file in stone bookEpidemiology

In a prospective study of two nurse (red) and one male physician cohort (blue) Curhan found that relative risk of kidney stone onset (vertical axis) rose as urine citrate excretion (shown in hexiles along the horizontal axis) fell. Below 400 mg/day of urine citrate risk was – compared to above 800 mg/day) increased by nearly 2 fold. Mean relative risk is at the ends of the shaded bars. The upper 95% of risk is at the tops of the filled bars. Even though the average risk (end of crosshatched bars) remained below 1.



Although I had quibbles with some of the comments it included, I believe the recent American College of Physicians (ACP) review of kidney stone prevention trials was done properly, and therefore have selected for review here those they felt were technically adequate.

Below is a detailed presentation of the five studies. Here is a link to my spreadsheet with all of the numbers. It also contains my references for thiazide treatment.

Ettinger et al (J Urol 158:2069-2073, 1997).

Sixty four patients with at least 2 stones in the past 5 years and at least 1 within the past year before the trial were given placebo (33 cases) or potassium magnesium citrate (63 mEq citrate, 42 mEq as potassium and 21 mEq as the magnesium salt in combination pills) – 31 cases. Each pill contained 21 mEq of citrate; 2 pills were taken 3 times a day. The trial was designed to last for 3 years. There were 5 and 9 women in the placebo and treatment arms. Urine citrate excretions were not different before treatment (549 and 587 mg/day, respectively, nor were urine volume, pH, calcium, oxalate, or any other stone forming risk. After a one month grace period in which new stones were not counted, any passage or radiographic appearance of new stones, or growth of previous stones was considered a treatment failure. During the trial, 15 subjects left the treatment arm, 8 the placebo arm.

New stones or growth of old stones occurred in 63.6% (16 cases) of the 25 placebo cases who finished the trial and in 12.9% (2 cases) of the 16 treated cases who finished the trial. If the 6 subjects who left the treatment arm because of drug adverse effects are added in as treatment failures the drug effect remained significant (8 of 22 or 33%).

Of note, this particular formulation is not available in the US. A version of the supplement is available OTC but the dose per pill is so low that it is impractical for anyone to use it. So the trial is part of a proof of principle, but not actually applicable to clinical practice in this country.

Lojanapiwat et al (International Braz J Urol 37:611-616, 2011)

Unlike the Ettinger study, which concerned spontaneous stone formation, this study concerned new stones or growth of residual fragments after shock wave lithotripsy (SWL) or percutaneous nephrolithotomy (PERC). Their subjects were 80 initial patients, all 8 weeks after either procedure, and either stone free or having no residual stone fragments >4mm diameter (Numbers are in the Table). Hypocitraturia (<325 mg/day) was present in 20/39 who received citrate and 15/37 who did not.

  SWL PERC  Total
STONE FREE 24(8)  15(5)  39(13)
RESIDUAL STONES 26(17)  11(9) 37(26)
Total 50(25)  26(14)  76(39)

They were randomized into 39 treated and 37 placebo treated groups and followed for one year which 76 of the original 80 completed. Numbers receiving citrate in each group are in parentheses. Sodium potassium citrate was given as 81 mEq/day in 3 divided doses).

Of the 13 cases who were stone free and received citrate, 12 remained so vs. 15 of the 26 given placebo. Of the 26 who had retained fragments and were given citrate, 8 were stone free vs. 1 of the 11 controls and 16 others given citrate showed no change (13) or reduction in size (3) vs. 2, no change and 2 decreased size among the 11 placebo. These differences were judged significant at the p<0.05 level by the authors.

Soygur et al (J Endourology 16:149, 2002)

This trial considered 90 patients after SWL for lower pole stones who had residual stones <5 mm or were stone free. They were randomly assigned to potassium citrate (50 mEq/day in 3 divided doses) or placebo (Table). The trial lasted one year. The end

  Citrate  Placebo  Total
STONE FREE 28(0)  28(8)  56(8)
RESIDUAL STONES 18(0)  16(6) 34(6)
Total  46(0)   44(14)   90(14)

points were stone free or not and residual stone size increased or not.

New stones occurred (parentheses) in none of the citrate treated stone free patients and in 8 of the placebo treated patients. Among the residual stone group, the fragments disappeared in 8 treated cases and failed to grow or shrank in the others vs. growth or new stones in 6/16 placebo cases. The differences in growth or new appearance were all significant.

Of course, both of these post treatment trials are subject to the biases of a radiography study, but observers appeared to have been suitably blinded to the patient groups.

Hofbauer et al (British J Urol 73:362-365, 1994)

In this trial, an equimolal sodium / potassium citrate was given in doses that maintained urine pH in the range of 7 to 7.2 vs. placebo. Therefore, although patients were allocated randomly to active treatment or placebo, the trial could not be blinded. By the three year endpoint, 22/25 placebo and 16/25 active drug subjects remained. New stones occurred in 16/22 placebo and 10/16 active drug subjects. This difference was not significant. This study is the only one with a negative outcome. It is also the only study that was not double blinded.

Barcello et al (J Urol 150:1761, 1993)

Stone formers with urine citrate excretion rates below 643 mg/day (3.4 mmol/day) were allocated to potassium citrate 60 mEq/day in 3 divided doses. Their mean urine citrate excretion was 359 mg/day. At the end of three years of followup, 20/28 placebo treated and 18/27 citrate treated subjects remained. New stones occurred in 14/20 placebo and 5/18 treated cases, a significant departure from chance.


TREATED  20  115 135 
NOT TREATED 77 71  148
TOTAL  97  186 283 

Despite the variability of design, one can, with nerve, simply ask about the beneficial effects of citrate salts across all the trials. In all five trials 283 people completed the desired treatment period. Of these, 97/283 (34%) formed new stones or, in the case of the post procedure trials showed growth of retained fragments. Among all patients who were given citrate salts, 20/135 (14.8%) formed new stones or showed growth of retained fragments vs. 77/148 (52%) of those given placebo.

I have not added back the 6 cases from the Ettinger trial who left because of drug side effects.

From this we can reconstruct a sense of the value of the treatment as applied to the mixed practice of post surgical management and overall medical prevention.

Let us assume these numbers will hold for the future.

For every 1000 cases like the ones in the trials, 520 untreated cases will form new stones or show stone growth after a procedure vs. 148 cases/1000 cases with citrate, a savings of 372/1000 cases overall.

I realize I am not calculating in the most satisfactory manner as a statistician, but I rather like the coarse grained, even vulgar nature of my count me up.


A Personal View

The trial community exhibits the kind of methodological fussiness one expects and applauds in any scientific situation. Among their ilk the citrate effect is viewed as modest at best, the evidence, by their likes, fair.

I am sure they are right according to the mores and social instincts of this discipline, but I do not come from nor inhabit that discipline, and therefore have an altogether different way of counting – for that is all one does after the impatient and often indifferent subjects have played out their roles in the work.

How likely is it, I ask myself, that citrate salts do not prevent new stones or fragment growth?

Not at all likely.

Why assume anything but that blinding was performed when specified, that radiograph readers were competent and blinded to the groups patients were in, that stone events were counted fairly and compared to radiographs to estimate new stones? If we make these assumption of honesty and skill, the marked downward skew from alkali is just too large to be by chance.

My bet will be on the drug, and if I bet that way, I will always win.

Do We Need More Trials For Calcium Stone Formers?

For me, no. It would seem a waste of money.

Some trials treated patients with reduced urine citrate, others did not. Some trials looked at new stones over 3 years, others at residual fragment growth one year after urological procedures. Will another 50 or even 100 cases be likely to change the outcomes? If so, in what way, and why?

It is true that one trial showed no effect and that trial was not blinded. It is actually a drag on the results as I did not remove it.

We Do Need a Trial of Citrate for Calcium Phosphate Stone Formers?

I do not know how often this must be said. Calcium phosphate stone formers must lurk in each of the trials I have reviewed, but I do not know their outcomes. One trial insisted stones be at least >50% calcium oxalate. That means perhaps a few had considerable phosphate is stones.

Calcium phosphate crystal formation is sensitive to urine pH whereas calcium oxalate stone formation will not be. The reason is that calcium phosphate supersaturation requires divalent phosphate be present, and the pKa for the second proton is about 6.8. Citrate salts can raise urine pH, so they can raise supersaturation with respect to calcium phosphate salts. On the other hand, citrate is an inhibitor of crystallization both because it is calcium binding and because it directly affects calcium crystal growth.


The very same ACP report from which I derived the studies shown here presented an annoying set of comments that infers we might as well just give a drug like potassium citrate without knowing stone composition, or doing serum or urine testing that concerns stone pathogenesis.

For this reason, I offer some remarks on that subject. This is in the special context of citrate treatment. I have made more general remarks of a negative sort about the APC comments.

Does Stone Analysis Matter?

How can it not? I have already mentioned the problem of phosphate stones. Do we not have to exclude struvite is stones? The odd patient with cystinuria who has slipped by? Drug stones? Conversion from calcium oxalate to calcium phosphate stones?

Do Serum and Urine Testing Matter?

How can they not?


Do we want to give potassium loads to people with reduced renal function?

Having prescribed potassium, do we not want to monitor for serious increase in serum potassium; some patients are older, some diabetic, some take ACE or ARB medications, some age or change drugs over the years we treat them.

Do we not want to diagnose primary hyperparathyroidism? You cannot without serum testing and 24 hour urine testing to be sure calcium excretion is not low.


If we do not obtain and measure 24 hour urine samples, how can we know anything? Some patients may have very high urine citrate levels. Some may have very high urine pH values.

Here and there urine oxalate is very high, from primary hyperoxaluria, or occult malabsorption syndromes, or very odd food habits.

People change their habits and develop diseases.

Moreover, people do not always take their citrate. Fall in urine ammonia in relation to urine sulfate, and rise in urine potassium assure one they are taking the drug.


Do We Need a Trial for Uric Acid Stone Formers?


No one really questions that alkali salts will raise urine pH, nor that raising urine pH will reduce uric acid supersaturation and prevent stones. It is common practice. I doubt anyone will pay for or perform an RCT to test this question.

That they will not is very important, because it raises an unexpected question.


We Know the Chemistry

Uric acid is a large flat mainly hydrophobic molecule with most of its charge on a single proton receptor site. The protonated from has a very low solubility in urine of around 90 mg/liter whereas 24 hour urine uric acid excretion ranges from 400 to over 1000 mg daily depending upon diet purine loads. The pKa of the proton receptor site is about 5.3 in urine. 

Given these facts we can calculate uric acid supersaturation from the urine concentration of total uric acid and the pH, along with minor adjustments for the effects of ionic strength on the pKa. High supersaturation will lead to a snowstorm of uric acid crystals. Raising urine pH to above 6 will generally reduce supersaturation below 1 and end uric acid stone formation.

Everyone Knows Alkali Work

There is a lot of uric acid excreted every day, so uric acid stones can grow rapidly. Uric acid gravel has an orange red color and is often seen. When alkali are given, the gravel goes away only to come back if patients miss doses. The absence of new stones is obvious.

No One Treats Without Stone Analyses

Who can be sure of stone composition without stone analysis? Even during treatment of someone who has produced uric acid stones, calcium oxalate or calcium phosphate stones may begin. So people know the stone type, and proceed by custom.

No One Treats Without Testing Serum and Urine

Uric acid stones are common in diabetics and people with reduced renal function; potassium loads are potentially dangerous. Perhaps this is more obvious among uric acid stone formers than calcium stone formers, although given wide spread use of ACE and ARB drugs and NSAIDS, potential risk is everywhere.

The amounts of alkali needed can be variable, and the only reliable way to ascertain is 24 hour urine testing. Likewise for compliance.

Therefore routine practice monitors before and during potassium citrate treatment of uric acid stones.


IN this situation, no one has and probably no one will propose a trial of alkali for uric acid stones. But, there is an almost exact parallel situation for calcium phosphate stones, yet such certainty as pertains to uric acid stones certainly does not exist.


Do We Need a Trial for CaP Stone Formers?



We Know the Chemistry

Calcium cannot combine with mono-valent phosphate but only with the divalent form. The pKa for dissociation of the second proton of phosphoric acid is about 6.8 in urine, although the precise value varies with ionic strength. Given the molarities of total phosphate, calcium, citrate – which binds calcium – and other ligands that have modest effects, the supersaturation of brushite – the usual initial urine CaP phase – can be calculated as well as we can calculate the supersaturation for uric acid.

Like uric acid, phosphate and calcium are abundant in urine, so the amount of crystal that can be produced in a day is similar to that of uric acid. Therefore stones can, and do, form rapidly and become large.

As in the case of uric acid, high urine CaP supersaturation can produce snows storms of crystallization; though certainly not common, patients can recognize this as white urine.

On physical chemical grounds, to lower CaP supersaturation below one and keep it there is to prevent CaP stones as surely as one prevents uric acid stones by raising urine pH and lowering supersaturation below one. Why, then, is not this treatment as self evident as alkali for uric acid stones?

Everyone Does Not ‘Know’ Treatment Works

We have no drug corresponding to alkali.

We can raise urine pH safely but cannot lower it.

Acid loads raise urine calcium losses and can be detrimental to bone mineral balance. Higher protein intake is a possible way to lower pH, but not all kidneys respond to acid with a prompt fall in pH. In some cases urine ammonium ion excretion will rise. In others, acid retention may occur. Urine calcium will tend to rise.

So treatment is not as transparent as for uric acid.

But Treatment Must Work Exactly the Same Way

We can lower CaP below 1 with fluids and measures – reduced diet sodium and thiazide – that reduce urine calcium, and we can monitor supersaturation as we monitor urine pH and uric acid supersaturation.

Furthermore, patients can tell if white urine has ceased.

Moreover, because stones are often actively forming, effective treatment is reasonably obvious.

However, these measures may be difficult to achieve. Thiazide is not always tolerated, reduced salt diet not always maintained.

Citrate is a powerful inhibitor of crystals, and it would be good to know if it were beneficial for the CaP stone former.





  1. Laurel Jenner

    As a long time patient of your clinic at University of Chicago, I have spent much time researching this disease. I’m so greatful for the advances made in treating this disease. I have calcium phosphate stones. I also suffer with Lupus and Primary Immune Deficiency. I wonder if either of those diseases have caused my gravel pits known as kidneys. I’ve had at least 10 lithotripsies (I lost count), and currently have 5 and 6mm stones along with many 2mm stones in each kidney. I take 25mg of Chlorthalidone daily. This drug has greatly reduced my stone formation, but also my potassium levels. It was impossible with potassium cholride alone to get it in the normal range. I take Amiloride 10 mg 2x a day and 60 meq Potassium Chloride. This keeps my level around 3.5. I strive for a low phosphate – low sodium diet, along with at least 2.5 liters fluid a day. Thanks to Dr. John Asplin and then Dr. Anna Zisman for their great care and guidance – I’m doing well. I’m fortunate to live within 2 hours of the clinic. I have not been there in several years as I see a local Urologist, Dr. Brian Keuer and a Nephrologist, Dr. Donald Cronin, for my care. Both my fine doctors have stressed increasing citrates as you have in your published articles. My urine ph level is quite high, Dr. Zisman believes the reason is too many lithotripsies. My question is: what ph level should be strived for with calcium phosphate stones?

    p.s. I’d be happy to be included in a study as you stated not many have been done for my type of stones.

    • Fredric Coe, MD

      Hi Laurel, Dr Zisman is my partner, and she should answer this. I am sure she mentioned that immune disorders can cause renal tubular acidosis with high urine pH and calcium phosphate stones. I am sure your local physicians are excellent. If there are any problems, we are here to help. Presently we are not doing a study related to your stone type but thank you for the offer. Regards, Fred Coe

      • Laurel Jenner

        My diagnoses of Lupus and Primary Immune Deficiency came after my last appointment with Dr. Zisman, although my symptoms all existed. This is the first I have heard of renal tubular acidosis, it sure answers my question – why am I a stone former. I will make an appointment with Dr. Zisman to follow-up on this important issue. Thank you very much!

        • Fredric Coe, MD

          Hi, Laurel, I only made a suggestion. But Dr Zisman is very skilled and if your immune disorders have caused RTA she will certainly be able to help. Regards, Fred Coe

  2. toolate

    Does Magnesium Citrate work for calcium oxalate stone formers?

    • Fredric Coe, MD

      Hi toolate, There is no known role for it. But the question makes me wonder if you really know what is the best way to prevent your stones. Take a look here and be sure you have checked things out fully. In general, stones are a technical thing – crystal formation follows physical laws – so treatment is very particular. Regards, Fred Coe

      • toolate

        well in my case, stones are 90% Calcium Oxalate, 10% phosphate. 24 hour urine showed nothing remarkable.
        Adequate intake of water has been a problem!

        I like to take Magnesium citrate anyway is why I asked, and I have heard lots of anecdotes from stone formers that Magnesium helped them.

      • toolate

        I should add: I do not seem to be forming new stones over a 4 year period BUT i do have one remaining stone of 10 mm which i would prefer not to remove surgically and was wondering if shrinking calcium oxalate stones by means of fluids, diet and medications is a possibility?

        • Fredric Coe, MD

          Hi Toolate, I think dissolving calcium oxalate stones is very unlikely – too insoluble. Regards, Fred Coe

          • toolate

            Thank you. Any sense of whether stones that are not causing any symptoms and are relatively stable need intervention? Any trials about this?

            • Fredric Coe, MD

              Hi, No trials. Stones need to be removed if they cause obstruction, infection, severe pain, or bleeding. Otherwise the problems of surgery are not justified. Regards, Fred Coe

              • toolate

                Thank you for that opinion! But isnt the risk of the various procedures increased if one waits for infection or obstruction?

              • Fredric Coe, MD

                Hi toolate, It is not an opinion but a generalization. If the stone is not obstructing, and pain, infection, and bleeding are not present – your physician needs to assure this – removal is not known to benefit patients in the long term. Your physician may offer surgery because of the details of the stone position or your kidney anatomy. Regards, Fred Coe

              • toolate

                Once again thank you for your kind and thoughtful reply!


    Would taking Calcium Citrate 200mg with lunch and dinner accomplish the same results as taking potassium citrate?
    My last stone analysis showed 70% uric acid and 30% Calcium citrate. That’s something that my doctor recommended but I hesitated taking a Calcium supplement.

    Thank you for your great website

    • Fredric Coe, MD

      Hi James, No. Your stones are mainly uric acid and you need to get the urine pH up above 6 to stop them. WHen you are there get another 24 hour urine and figure out the reasons for the calcium part of your stones. Regards, Fred Coe

  4. Anthony Krall

    I submitted a comment earlier this morning but haven’t heard from you.

  5. Lisa Hess

    Dr, Coe,
    I am a 47 yrear old female with 1 solitary kidney. (1 was removed at 10yrs of age) I was diagnosed with cystinuria. Most of my life was stone free until 2015. I had 2 Uteroscopy laser procedures to break up the stones. 1 cystine stone was 18 x 9 mm. I passed literaly hundreds of stones after the surgery. I thought i was doing good. However after a blockage of passing a very large stone. A CT scan showed that my kidney was once again full of stones in less than 1 year. This summer 2016 I had a Percutaneous Nephrolithotomy. It was not a pleasant experience to say the least. I am petrified of getting the stones back again. I am on Hydrochlorothizide 25 mg to produce even more urine flow . Drinking 101 oz of water a day and lowering to the bare minimum of protein. However, I will be seeing a dietician soon. However, I have not been put on Potassium citrate yet. I just dont want to go on Thiola before trying a less radical treatmet.

    • Fredric Coe, MD

      Hi Lisa, You have a really major problem, and I like some of what you are doing. Massive fluids evenly spaced out over the day is a huge benefit for you. The OHCTZ will not raise urine volume; only water intake can do that. I presume your physician found a high urine calcium level and is trying to reduce it to stave off calcium overgrowth on the cystine stones. Low protein diet can help as can potassium citrate to raise urine pH above 7. But with one kidney and many stones perhaps your physicians would want to add the Thiola sooner than later – if you can take the drug without side effects. Regards, Fred Coe

  6. Kris

    Hello Dr. Coe,

    I would assume this information is also beneficial for gout sufferers?

    I do not suffer from kidney stones (yet) but I do suffer from gout – uric acid crystals that settle for the most part in and around my fingers and more so during winter and cold.

    Would citrate therapy help?

    Best regards,

    • Fredric Coe, MD

      Hi Krisof, It is not. Gout involves crystallization of sodium hydrogen urate in joint fluid, stones in involve crystallization of uric acid – dihydrogen urate – in urine. Potassium citrate will not make a known measurable change in joint fluid, but will in urine. For gout one proceeds in an entirely different manner. Regards, Fred Coe

  7. Elizabeth

    Hi Dr. Coe:
    I have been reading over your site and have found it very interesting. I have battled with kidney stones for well over twenty-eight years now….my first stone was in my teens. For many years the stones were made of uric acid and a physician finally placed me on 300mg of allopurinol once a day. I have been through countless cystoscopic stone retrievals in the 90’s, and a right nephrectomy when I was twenty-eight due to hydronephrosis due to ureter damage from stent placements and stones. I did well for ten years or so after the nephrectomy, and then I started producing calcium stones. I have had several SWLs, and ureteroscopes over the past few years. I’ve completed 24 hour urine tests over the past several years and found to be hypercalciuria. My medication regime consists of allopurinol 300mg (for over 26 years now), HCTZ (over 10 years), and estradiol 1.5mg (surgical menopause one year after nephrectomy). When my physician put me on the HCTZ he stated I needed to be sure to eat alot of bananas due to the thiazide lowering the potassium levels.
    I’m battling yet another stone as I write this. I have added flomax temporarily to help relax the muscle and ureter in hopes it will soon pass; however passing stones has never much worked in my favor. I can certainly produce stones….just can’t eliminate them!
    It has now come to the point when I go into my physician’s office he doesn’t even question when I say to him I have another stone (this after having a SWL to fragment a stone only to return two weeks later due to another ….which was removed through a ureteroscope). I have been given the whole lists of foods to avoid, what not to drink, eat, etc….and none of it makes a difference.
    Water is my main beverage throughout the day/evening and even when dining out. I carry it wherever I go. I stay clear of sodas, but will have an occasional clear soda or lemonade just to mix things up a little. Tea and Coffee are never even a choice, and I don’t drink alcoholic beverages. I consume very little red meat, and dairy products.
    I’m just in my early forties, and having a solitary kidney I am always concerned! I am concerned about the many CTs, along with the many other radiation treatments I’ve received. Aside from being a frequent stone producer I consider myself to be in great health. I’m desperately searching for ways to manage this uncomfortable, painful condition I’ve dealt with for so many years. I have to wonder if my body has possibly become immune to the medication I’m on.
    Thank you, I look forward to your suggestions.

    • Fredric Coe, MD

      Hi Elizabeth, This is a very serious problem and I am sure your physicians are very concerned to prevent stones. If calcium, what kind?? Calcium phosphate, brushite, calcium oxalate? Are they mixed, and in what proportions. How well is your hypercalciuria controlled? Take a look at an approach to prevention and be sure everything is as it should be. If you have active stones, you need to lower the supersaturation(s) relevant to the crystals in your stones. There is no reason for continued stone formation. Regards, Fred Coe

      • Elizabeth

        Dr. Coe,
        I’m almost embarrassed to say I don’t really know. I’ve only completed two 24 hour urine studies over the last ten years with the latest being done in 2011. Each time these studies were done through Litholink. My annual visit usually consists of just checking a urinalysis. The only time a CT or ultrasound is done is if I go in with problems, and blood tests are not completed unless I’m hospitalized. Despite the medications, I seem to always be actively making stones. My last CT was this time last year when I was in for a stone, and at that time I had three more higher in the kidney which are always left alone. I am so glad I have discovered this site. The information has been so insightful. I will be seeing my physician in a couple weeks, and will be requesting a 24 hour urine as well as blood work. I have to find a way to get to the bottom of this.

  8. Chris Athas

    I have just had my 5th ureteroscopy in the last 5 years my doctors cannot seem to prevent them Please Help

  9. Joan Pfeiffer

    Can bringing up pH w/ ascorbic acid instead an option? How about diets that do this?

    • Fredric Coe, MD

      Hi Joan, Ascorbic acid can raise urine oxalate and will not make urine pH go up. I would not pursue it as a treatment. Regards, Fred Coe

  10. James Albrecht

    I just had a ureteroscopy (and stent) to remove a 6mm uric acid stone. I am now taking a 1080 mg Potassium Cirtate tab once daily and drinking 100 ounces of water per day. Is this sufficient to prevent another stone or is other diet alteration needed? Could other types of stones be formed instead without diet changes?


Leave a Reply